GE HealthCare Technologies Inc.
NASDAQ · GEHCGE HealthCare Technologies Inc. (“GE HealthCare,” the “Company,” “our,” “us,” or “we”) is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. We have approximately 54,000 colleagues dedicated to our purpose to create a world where healthcare has no limits. Serving patients and providers for nearly 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine to help clinicians deliver more personalized, precise patient care. This is complemented by our broad service capabilities and dedication to quality and integrity with a strong operational culture, supported by our lean business system, Heartbeat. We generate revenue from the sale of medical devices, consumable products, service capabilities, and AI-enabled cloud and software solutions. We serve customers in over 160 countries with a global team of approximately 9,700 sales professionals and 8,900 field service engineers. Our customers are hospitals, health systems, and researchers, including public, private, academic, and government institutio
From the 10-K filed Feb 4, 2026
as of Oct 22, 2026 · today 76.57, 58% of the way from low to high
Valuation
Results, trailing twelve months
Balance and cash
Shares and market
Financial statements
Total revenues +4.8% $19.67B → $20.63B, year ended Dec 31, 2025
Comps
Valuation, growth and margins against the closest competitors
Filings
10-K filed Feb 4, 2026 · 10-Q Oct 28, 2026
| Filing | Filed |
|---|---|
| 10-Q for Quarter Ended September 2026 | Oct 28, 2026 |
| 10-Q for Quarter Ended June 2026 | Jul 29, 2026 |
| 10-Q for Quarter Ended March 2026 | Apr 29, 2026 |
| 10-K for Fiscal Year Ended December 2025 | Feb 4, 2026 |
Insiders
No sales $6.42M bought · open market, 12 months to May 22, 2026
| Insider | Type | Value |
|---|---|---|
| Kevin LoboMay 22, 2026 | Purchase | $641.80K ↗ |
| Rodney F HochmanMay 12, 2026 | Purchase | $100.36K ↗ |
| Watkin Phoebe L. YangMay 8, 2026 | Purchase | $63.01K ↗ |
| Lawrence H Culp JRMay 6, 2026 | Purchase | $5.00M ↗ |
Funds (13F)
87.8% held by 1,269 managers · as of Sep 30, 2026
| Manager | Value | Change |
|---|---|---|
| Dodge & Cox | $2.42B | +6.55M (+20.9%) |
| BlackRock, Inc. | $2.40B | +1.48M (+4.1%) |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.90B | +860.17K (+3.0%) |
| STATE STREET CORP | $1.34B | +323.09K (+1.6%) |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.30B | +1.09M (+5.7%) |
Congress
17 trades 8 sales · 9 purchases · 4 members, 12 months
| Member | Type | Amount |
|---|---|---|
| Ro KhannaSep 11, 2026 | Purchase | $1K–$15K |
| Ro KhannaAug 3, 2026 | Purchase | $1K–$15K |
| Ro KhannaJun 30, 2026 | Purchase | $1K–$15K |
| Ro KhannaJun 30, 2026 | Purchase | $1K–$15K |
Short interest
4.30% of float · 5.13 days to cover · Oct 15, 2026
Short position, last two years · near a 2-year high
Source: FINRA
In the press
| Headline | Source | Published |
|---|---|---|
| GE HealthCare introduces AI-enabled imaging system for cardiac procedures (GEHC:NASDAQ) ↗ | seekingalpha.com | Nov 1, 2026 |
| GE HealthCare (GEHC) Q3 2026 Earnings Call Transcript ↗ | fool.com | Oct 28, 2026 |
| GE HealthCare stock rises after Q3 beat (GEHC:NASDAQ) ↗ | seekingalpha.com | Oct 28, 2026 |
Headlines indexed by The GDELT Project ↗, matched by company name, so one may be about something else. Each opens on its publisher’s site.
Company data reported to the SEC on EDGAR (CIK 1932393).
Member research
Everything on GEHC, in full
Every fiscal year and quarter as filed, the filing reader with highlights and AI summaries, insider and fund activity, congressional trades, short interest history, earnings calls, the full price history and every peer. A 7-day free trial, then a subscription.